Hexamethonium chloride is an autonomic ganglionic blocking drug which has been reported to be effective in reducing blood pressure (1-3). In patients with severe hypertensive vascular dis,-ease the brain and the heart appear to be benefited by a moderate reduction in blood pressure (2-5). However, since glomerular filtration is dependent upon systemic blood pressure, one might anticipate that renal excretory capacity may be affected adversely by this procedure, particularly if kidney disease is associated with the hypertension. For this reason, the following study was undertaken, in which renal functions were evaluated before and after reduction in blood pressure with hexamethonium.2 The studies were carried out on control subjects with normal blood pressure and on patients with hypertension with and without renal damage as estimated by glomerular filtration rate.
Hexamethonium chloride is an autonomic ganglionic blocking drug which has been reported to be effective in reducing blood pressure (1) (2) (3) . In patients with severe hypertensive vascular dis,-ease the brain and the heart appear to be benefited by a moderate reduction in blood pressure (2) (3) (4) (5) . However, since glomerular filtration is dependent upon systemic blood pressure, one might anticipate that renal excretory capacity may be affected adversely by this procedure, particularly if kidney disease is associated with the hypertension. For this reason, the following study was undertaken, in which renal functions were evaluated before and after reduction in blood pressure with hexamethonium.2 The studies were carried out on control subjects with normal blood pressure and on patients with hypertension with and without renal damage as estimated by glomerular filtration rate.
METHODS
Observations on the effect of hexamethonium administered intravenously were made on 14 control subjects (six men and eight women) with normal blood pressure and on 22 patients (13 men and nine women) with hypertension. Maximal tubular function (TmPAH) before and after blood pressure reduction was determined on four of the normal subjects and on six of the patients with hypertension. Para-aminohippurate (PAH) at plasma levels of 60 to 90 mg. per 100 ml. of plasma was used for this measurement. The analytical method of Smith and his associates (6) was used for the determination of PAH. The effect of blood pressure reduction on glomerular filtration rate (GFR) and on water and electrolyte excretion was determined on ten of the normal subjects (Group A, Table II ); on five of the patients (Group B, Inc. Table II ) with hypertension but relatively normal kidney function as determined by a GFRS of more than 80 ml. per minute; and on 11 of the patients (Group C, Table  II ) with hypertension and moderate to marked renal damage as determined by-GFR 8 less than 80 ml. per minute. Glomerular filtration (GFR) was determined in all patients by the inulin clearance method at plasma levels of 30 to 60 mg. per 100 ml. of plasma. Roe's analytical technique was used (7) . Plasma sodium and potassium concentrations and the amounts of these electrolytes excreted in the urine were determined using a Beckman flame photometer for analysis. Electrolyte excretion was not determined on the patients on whom TmPAH studies were done because of the diuretic effect of PAH and because this agent increases urinary sodium excretion, thus obscuring any effect due to the hexamethonium.
The blood pressure was determined by the auscultatory method as well as by intra-arterial manometry. In a few patients on whom auscultatory observations alone were made, the mean blood pressure was calculated by the diastolic blood pressure plus one-third of the pulse pressure. The intra-arterial needle was connected to a mercury manometer through a manifold which was also used for collecting blood samples. Blood for analysis was collected two minutes prior to the midpoint of each 10-minute collection period. A mercury pump (8) was used for maintaining a constant intravenous infusion of inulin and PAH. Rising or unchanging blood levels of inulin and PAH were used. Experiments showing falling blood levels were discarded. Urine samples were obtained through an indwelling catheter using air and 100 ml. of distilled water as a bladder wash. Following the priming doses of PAH and inulin, a 30-minute equilibration period was allowed before the experiment was started. Control observations consisted of three or four consecutive 10-minute periods. Following the control studies, hexamethonium was administered slowly by the intravenous route over a 10-to 20-minute period. The dose of hexamethonium was determined largely by the blood pressure response to the drug. In the hypertensive patients, an attempt was made to reduce the mean blood pressure 20 to 30 mm. of Hg or more, unless the patient experienced uncomfortable side reactions. The mean blood pressure was reduced approximately 10 to 20n mm. of Hg in the normal control subjects. Renal function studies (10-minute periods) were carried out during the drug administration and for one to two hours thereafter. Five patients were studied for three hours.
In addition to the previous studies, the effect of norepinephrine infusion after hexamethonium was determined on nine patients. Norepinephrine was given to two of these patients as a therapeutic measure. The study was conducted on the remaining seven only for purposes of evaluating renal hemodynamic response. In this phase of the study, the control renal function observations were carried out as outlined above. When maximum hypotension was established and the blood pressure stabilized for 30 minutes (Patients Nos. 1 and 2 excepted) or more, norepinephrine was administered by continuous infusion using a concentration of 4 micrograms per ml. of 5 per cent glucose. The height of the blood pressure was regulated by the rate of infusion. Renal function studies were then repeated using the same technique as previously outlined.
RESULTS
The blood pressure response to the intravenous administration of hexamethonium in one of the patients is seen in Figure 1 . Within ten minutes there was a sharp reduction in blood pressure in most patients, followed by a slight rise and then stabilization at a point somewhat above the lowest level attained. In a few patients the blood pressure decreased slowly and progressively over a 10-to 20-minute period. A reduction in blood pressure was obtained in all patients included in the present study. However, three additional patients who received the drug were not included because there were no significant alterations in blood pressure or in renal function. The percentile reduction in systolic and diastolic pressures were about equal with a resultant decrease in pulse pressure. There was no significant increase in pulse rate. The blood pressure in most of the patients remained at this reduced level for one hour or more and then slowly rose so that after three to four hours it was back to or approaching the control level. However, in some patients, a significant reduction in blood pressure persisted for eight to 12 hours (Figure 1 ). The effects of hexamethonium on blood pressure and pulse rate are summarized in Table I Figure 2A represents the observations during maximum reduction in blood pressure (D2). Figure 2B represents the observations one hour after the administration of hexamethonium. Urine is reduced more than glomerular filtration rate during both periods of observation. There is essentially no difference between the normal patients and those with hypertensive vascular disease. marked during the period of drug administration, there was a gradual return toward control levels. After one hour, GFR approximated the control observations in the majority of both normotensive and hypertensive patients. In this respect, there was a difference in the hypertensive patients with renal damage and those without. At the point of maximum reduction in blood pressure (D2) both the normotensive and hypertensive patients with normal renal function apparently adapted to the reduced pressure more rapidly than those with renal damage. As a result, the average GFR for the normal group was 90 per cent of the control; the average GFR for the hypertensive group with normal kidneys (Group B) was 87 per cent of the control; but for the patients with renal damage it was 72 per cent of the average of the control observations. This difference in renal readjustment to the reduced blood pressure could also be noted after one hour. The mean value for GFR in the normal group was 103 per cent of the control, while in the hypertensive patients with renal damage, it was only 89 per cent. The differences in adaption to lowered pressure were greater in some patients than in others since the number of patients in whom GFR failed to return to absolute control levels was about equivalent in both groups. This is of significance in that the excretory capacity as reflected in blood urea nitrogen was already impaired in many of the patients in the latter group. Therefore, only a small reduction in GFR could be expected to depress further (at least temporarily) renal excretory function in contrast to the wide margin of renal excretory reserve which exists in patients with relatively normal kidneys.
The reduction in blood pressure following hexamethonium was associated with a marked antidiuretic effect whether or not glomerular filtration rate (GFR) was reduced. Figure 3A includes the observations during maximum reduction in blood pressure and Figure 3B those one hour after the administration of the hexamethonium. Sodium reabsorption is increased out of proportion to the reduction in glomerular filtration rate. One hour after hexamethonium, the glomerular filtration rates are returning toward the control values more rapidly than sodium excretion rates. no obvious differences between the normotensive and the hypertensive patients and those with and without renal disease. After one hour (D3) GFR approached or returned to the control values, but the urine volumes remained depressed to about the same degree as during period D2. There was one exception (Sa., Table II ) who was a patient with marked renal damage. In this instance, urine volume after one hour was greater than during the control period. The antidiuretic effect of acute reduction in blood pressure after hexamethonium is also reflected in the increasing U/P ratio of inulin. This was less pronounced in the patients with reduced filtration rate than in the other two groups.
Associated with the antidiuretic effect following hexamethonium, the renal tubules reabsorbed a greater proportion of the filtered sodium, resulting in a decreased excretion of this electrolyte in the urine. This also occurred independently of glomerular filtration} rate, which can be visualized in Figures 3A and 3B . Here GFR for each patient is plotted against sodium excretion. Both are expressed in per cent of the control observations. During period D2 all of the points for GFR but one fell on or above the line of unity when compared with sodium excretion. The exception again was a patient (Pe., Table II ) with hypertension and renal damage. After one hour, the points continued to fall above the line of unity ( Figure 3B ), although there was some increase in sodium excretion. There were two exceptions (Sa. and Pe.), both patients with renal damage. Otherwise, it appeared that the normotensive patients and the hypertensive ones with and without renal damage responded in a similar manner. As a rule, impaired renal function as estimated by reduced GFR did not alter this effect. This response was maximal during the greatest depression, in blood pressure (D2) showing a reduction in sodium excretion of 50 per cent or more for the group.
The relationship between the reduction in urine volume and sodium excretion is graphed in Figures Figure  4B ).
The excretion of potassium was depressed in some patients following hexamethonium but this was inconstant. There were no significant alterations in plasma sodium (Table II) and potassium during this study. Observations on five patients two to three hours after hexamethonium administration showed that the renal clearance studies all returned to control values before the blood pressure did.
When the effect of acute blood pressure reduction on maximum tubular function was determined (Table III) , the glomerular filtration rate was reduced in essentially the same manner as during the previous studies (Table II) . However, maximum tubular excretory capacity of PAH was not altered significantly. This is reflected in a decrease in the GFR/TmPAH ratio. It indicates that the number of functioning nephrons did not change as the blood pressure decreased., either in the normotensive group or in the patients with hypertension. The reduction in GFR resulted from decreased filtration in the active glomeruli. Kidneys showing impaired renal function as defined in this study responded in the same way as in the normal.
The response to norepinephrine after hexamethonium was evaluated in nine patients (Table  IV) , to two of whom it was given as a therapeutic Figure 5A ) had previously taken an excessive dose of hexamethonium orally, following which the mean blood pressure decreased from 140 to 63 mm. Hg and she became anuric. Renal function was measured during the control period and after the blood pressure was raised with an infusion of norepinephrine. Following an increase in the mean blood pressure to approximately 115 mm. Hg, the GFR and urinary output increased progressively; the hexamethonium was excreted and recovery was uneventful.
In the second patient (Patient No. 2, Table IV and Figure 5B ), the mean blood pressure decreased from 165 to 95 mm. Hg following which the patient became mentally confused and disoriented. Glomerular filtration was depressed from 67 to 13 ml. per minute. Norepinephrine was started and the blood pressure increased. Cerebral function returned to the control state and at the same time the GFR increased to 45 ml. per minute ( Figure 5B ). However, when norepinephrine was discontinued after 20 minutes, the blood pressure and GFR were again depressed. There was an acute reduction in blood pressure associated with depression of GFR. The latter gradually returned to the control level despite a maintained reduction in blood pressure. When the blood pressure was increased to the control values with norepinephrine, GFR was slightly depressed.
for 20 minutes the blood pressure became better stabilized.
Norepinephrine was given to seven additional patients in order to evaluate better the renal response under these circumstances. The effect on GFR is variable and appears to be dependent on the degree of depression following the administration of hexamethonium. In general when GFR is markedly depressed by hexamethonium, norepinephrine tends to increase it toward the control values at the same time that the blood pressure is increased ( Figures 5A-5B ). However, in those patients in whom GFR was not markedly depressed (Figure 5C ) from the control period, raising the blood pressure with norepinephrine seemed to have little effect on GFR, or actually reduced it ( Figure 5C ). In three patients thus studied, TmPAH was not affected significantly by this procedure. Raising the blood pressure with norepinephrine had very little effect on the antidiuretic effect of hexamethonium although sodium excretion was enhanced.
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DISCUSSION
The present observations indicate that ganglionic blockade with hexamethonium was a dependable method for reducing the blood pressure in both normotensive and hypertensive individuals. As the blood pressure decreased, there was no associated reflex tachycardia, probably a result of the ganglionic blockade of the sympathetics to the heart. With some exceptions, the marked reduction in blood pressure in patients exhibiting hypertension again emphasizes the importance of the autonomic nervous system in this malady. Associated renal disease did not affect this response, suggesting that even when the kidneys are involved, imbalance of the autonomic nervous system usually plays a significant role in the development of the elevated blood pressure.
The observation of acute depression of glomerular filtration rate (GFR) following ganglionic blockade and blood pressure reduction with hexamethonium is in contrast to similar studies on anesthetized dogs (9) . In the latter studies, the initial depression of GFR was not seen, indicating more rapid readjustment of renal hemodynamics in dogs. Likewise, it appears that GFR in patients with normal kidneys tended to readjust to changes in blood pressure more rapidly than it did in patients with damaged ones. However, one hour after the hexamethonium was given, these differences were not so apparent, and very little depression of GFR was noted despite the maintained reduction in blood pressure. This response of patients to hexamethonium is qualitatively similar to autonomic blockade with tetraethylammonium (10) . After the latter drug there is also an initial depression of renal function followed by readjustment to a lower blood pressure. Subsequently, renal functions gradually return to control levels.
The renal dynamics in patients with hypertension respond to hexamethonium in essentially the same way as do those in patients with normal blood pressure. Patients with evidence of moderate to severe renal disease react qualitatively in a similar manner. This indicates that the nephrons that remain functional apparently react in a normal fashion and supports the contention that in the damaged kidney nephrons are destroyed as anatomical and functional units. Those nephrons that remain, function in a relatively normal fashion. There is no evidence to indicate why glomerular filtration is reduced and remains depressed in some patients more than others despite equivalent absolute blood pressure reductions in both.
In patients with relatively normal kidneys, as long as the blood pressure is not reduced below critical filtration levels, renal excretory capacity will be adequate, even though GFR may be somewhat depressed. However, when renal excretory capacity and' glomerular filtration are already impaired due to anatomical changes in the kidneys, then only slight reductions in GFR may further jeopardize this excretory capacity and thus decompensate the renal mechanism. There seems to be no way to predict which patients will not readjust their renal hemodynamics and filtrating capacity to a lower blood pressure, since some of the patients with the most renal damage readjusted as completely as the normotensive ones, although the former was at a higher absolute level of blood pressure. If the blood pressure in patients with hypertension and renal damage is reduced to the same absolute level as the normotensive patients, then more marked depression of renal function (GFR) may occur. This was seen in several instances in the present study and suggests that in the therapy of hypertension associated with renal damage, treatment should be aimed at post-drug blood pressures somewhat short of normotensive levels. If decreased excretory capacity follows blood pressure reduction with hexamethonium, the pressure should be allowed to increase to such a point that excretory function is not impaired in excess of that which is due to existing anatomical damage. This can best be evaluated on a longterm clinical basis by closely observing the level of blood urea nitrogen. However, the present studies were not designed to establish the longterm therapeutic efficacy of hexamethonium.
The cause of the decreased water and sodium excretion is not apparent. It is not due to an increase in the number of functioning nephrons available for sodium and water reabsorption since TmPAH was not altered by ganglionic blockade and blood pressure reduction. It cannot be explained solely on the basis of reduced glomerular filtration since in many instances it occurred independently of this function. In addition, one hour after hexamethonium was administered glomerular filtration had returned to the control levels in most of the patients, but a reduction in the rate of water and sodium excretion persisted. It apparently was not due to the liberation of endogenous antidiuretic hormone since this hormone does not increase sodium reabsorption in man (11) . Other investigators (12) (13) (14) have found that activity of the sympathetic nervous system alters tubular reabsorption of sodium and water. Renal denervation (13) in an unanesthetized dog did not affect GFR or electrolyte excretion, suggesting that the sympathetics had very little to do with this regulatory mechanism when the animal was not under stress. Sartorius and Burlington (14) found an increase in sodium and water excretion following denervation of the kidneys in anesthetized dogs, apparently due to the release of sympathetic neurogenic influences which are present in the anesthetized animal. A similar response was found by Moyer and his associates (9) after autonomic ganglionic blockade with hexamethonium in anesthetized dogs. Because of the possibility that anesthesia may previously have produced a sympathomimetic effect on the dogs' renal dynamics, which was released by ganglionic blockade with hexamethonium, these studies have been repeated on three unanesthetized dogs. The results using the same techniques as previously described are presented in Table V . In these unanesthetized dogs (Table V) , GFR and renal plasma flow increased slightly as the blood pressure was reduced in each of the three animals thus studied. This was associated with an increase in sodium excretion. There was no essential difference between these observations and the previous ones using anesthetized animals suggesting that even in the unanesthetized animal, the autonomic nervous system may alter tubular reabsorption of water and electrolytes. These observations as well as the previous ones indicate that sympathetic neurogenic impulses to the kidney may cause an increase in tubular reabsorption of sodium and water in the dog. This is in contrast to the response of the patients observed in the current study, wherein ganglionic blockade (partial) enhanced sodium and water reabsorption rather than decreased it. It is possible that sodium and water excretion was depressed after hexamethonium was given because of sympathetic stimulation to the renal nerves, a result of the renal nerve ganglia not being blocked as completely as were the vasoconstrictor nerves elsewhere, thus causing a differential in vasoconstrictor activity within the sympathetic nervous system. In this instance, reflex vasoconstrictor impulses would emanate over the renal nerves as the blood pressure decreased, thus producing an initial sympathomimetic effect on the kidney. Vasoconstrictive impulses of this nature would also explain the initial reduction in glomerular filtration which occurred but which returned to normal despite a maintained reduction in blood pressure. If this were so, the difference in response between the present studies and the previous observations on dogs would merely indicate less complete blockade in the humans. However, it is quite possible that the difference in the type of response may be due to species differences.
Observations in the present study indicate very little, if any, inhibition of potassium excretion. It is of interest to note that potassium excretion did 1. Hexamethonium is an effective autonomic ganglionic blocking agent for reducing the blood pressure in both normotensive and hypertensive patients. The percentile reduction in systolic and diastolic blood pressures is about equal.
2. When the blood pressure is reduced with parenteral hexamethonium, there is an immediate reduction in glomerular filtration rate, sodium excretion and water excretion. However, after one hour, despite a maintained reduction in blood pressure, glomerular filtration rate returns to or approximates the control values. The antidiuretic effect persists but sodium excretion increases. At the point of maximum depression of blood pressure (D2) there is not a consistent relationship between the reduction in glomerular filtration rate and the decreased excretion of water and sodium. Urine volume and sodium excretion are depressed proportionally until the urine volume is decreased to 20 to 30 per cent of the control values or less, and then the urine volume decreases more than sodium excretion. The initial effect on the kidney has the appearance of sympathetic renal nerve stimulation.
3. Kidneys showing marked impairment of renal function respond to blood pressure reduction with hexamethonium in essentially the same way as do normal ones, indicating that the nephrons are destroyed as anatomical units, and those that remain, function in a relatively normal fashion. However, this adjustment in patients with renal damage occurs more slowly than it does in patients with normal renal function.
4. The decrease in glomerular filtration following hexamethonium is not due to a decrease in the number of functioning nephrons since maximum tubular function (TmPAH) is not altered.
5. Moderate reduction in the blood pressure of patients with moderate to marked impairment of renal function is feasible. In most instances the functional nephrons that remain in damaged kidneys show a slower but a relatively normal hemodynamic readjustment to a lowered blood pressure.
6. After reduction in blood pressure with hexamethonium, norepinephrine is an effective vasopressor agent. The effect of norepinephrine on glomerular filtration under these circumstances is variable. If the reduction in blood pressure is excessive and glomerular filtration markedly depressed, raising the blood pressure with norepinephrine increases the filtration. If glomerular filtration is not depressed as a result of hexamethonium, increasing the blood pressure with norepinephrine does not affect or may slightly reduce glomerular filtration.
